Arrhythmias in cardiac sarcoidosis: Diagnosis and treatment

Current Opinion in Cardiology

Volumn 27, Issue 2, 2012, Pages 181-189

  Nery, Pablo B ^a   Leung, Eugene ^b   Birnie, David H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

heart block; sarcoidosis; ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIMALARIAL AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GALLIUM 67; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; PREDNISONE; TECHNETIUM 99M; THALIDOMIDE; THALLIUM 201;

AGE DISTRIBUTION; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DEFIBRILLATOR; DEVICE THERAPY; DNA POLYMORPHISM; DRUG EFFICACY; ECHOCARDIOGRAPHY; GEOGRAPHIC DISTRIBUTION; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG SARCOIDOSIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SURVIVAL TIME;

ARRHYTHMIAS, CARDIAC; BIOPSY; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; HUMANS; PROGNOSIS; SARCOIDOSIS;

EID: 84857046505     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32834e4c7c     Document Type: Review

References (76)

1. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995; 119:167-172.
2. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: Recent advances and future prospects. Semin Respir Crit Care Med 2007; 28:22-35. (Pubitemid 46371213)
3. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006; 92:282-288. (Pubitemid 43131983)
4. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
5. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241.
6. Iwai K, Tachibana T, Takemura T, et al. Pathological studies on sarcoidosis autopsy. I: Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993; 43:372-376. (Pubitemid 23225816)
7. Iwai K, Takemura T, Kitaichi M, et al. Pathological studies on sarcoidosis autopsy. II: Early change, mode of progression and death pattern. Acta Pathol Jpn 1993; 43:377-385. (Pubitemid 23225817)
8. Dhote R, Vignaux O, Blanche P, et al. Value of MRI for the diagnosis of cardiac involvement in sarcoidosis. Rev Med Internet 2003; 24:151-157. (Pubitemid 36363008)
9. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120:1969-1977.
10. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005; 128:30-35. (Pubitemid 40994450)
11. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: Initial results of a prospective study. J Comput Assist Tomogr 2002; 26:762-767. (Pubitemid 35423381)
12. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008; 133:1426-1435. (Pubitemid 351893001)
13. Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270:461-469.
14. Koplan BA, Soejima K, Baughman K, et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006; 3:924-929. (Pubitemid 44103499)
15. Uusimaa P, Ylitalo K, Anttonen O, et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008; 10:760-766. (Pubitemid 351775278)
16. Vasaiwala SC, Finn C, Delpriore J, et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2009; 20:473-476.
17. Semenzato G. ACCESS: A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:83-86. (Pubitemid 41020012)
18. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164:2085-2091. (Pubitemid 34020250)
19. Crouser ED, Culver DA, Knox KS, et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 2009; 179:929-938.
20. Rybicki BA, Sinha R, Iyengar S, et al. Genetic linkage analysis of sarcoidosis phenotypes: The sarcoidosis genetic analysis (SAGA) study. Genes Immun 2007; 8:379-386. (Pubitemid 47163101)
21. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54:191-193. (Pubitemid 29410778)
22. McGrath DS, Goh N, Foley PJ, du Bois RM. Sarcoidosis: genes and microbes: soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-164. (Pubitemid 32601533)
23. Fawcett FJ, Goldberg MJ. Heart block resulting from myocardial sarcoidosis. Br Heart J 1974; 36:220-223.
24. Rajani R, Prasad S, O'Nunain S, et al. Heart block: A primary manifestation of sarcoidosis. Europace 2010; 12:284-288.
25. Ramachandran V, Stevens MP, Amin M, et al. Bi-fascicular block on EKG as the initial presenting sign of cardiac sarcoidosis. Int J Cardiol 2007; 118:e1-e2. (Pubitemid 46517678)
26. Ruiz-Arango A, Sharma GK. Exercise intolerance and multiple conduction abnormalities as first manifestation of cardiac sarcoidosis. South Med J 2008; 101:1059-1061.
27. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134:382-386. (Pubitemid 27431239)
28. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011; 4:303-309.
29. Cooper LT Jr, Blauwet LA. When should high-grade heart block trigger a search for a treatable cardiomyopathy? Circ Arrhythm Electrophysiol 2011; 4:260-261.
30. Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4:1292-1299. (Pubitemid 47457196)
31. Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome. Clin Cardiol 2004; 27:217-222. (Pubitemid 38451157)
32. Redheuil AB, Paziaud O, Mousseaux E. Ventricular tachycardia and cardiac sarcoidosis: Correspondence between MRI and electrophysiology. Eur Heart J 2006; 27:1430. (Pubitemid 43998076)
33. Britton KA, Stevenson WG, Levy BD, et al. Clinical problem-solving. The beat goes on. N Engl J Med 2010; 362:1721-1726.
34. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of longterm survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88:1006-1010. (Pubitemid 33042612)
35. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A linicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63:86-108. (Pubitemid 8146656)
36. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211. (Pubitemid 9092005)
37. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009; 20:578-583.
38. Fahy GJ, Marwick T, McCreery CJ, et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109:62-66. (Pubitemid 26017594)
39. Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a noninvasive method with ultrasonic tissue characterisation. Heart 2004; 90:1275-1280. (Pubitemid 39433985)
40. Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985; 110 (1 Pt 1):116-122. (Pubitemid 16119690)
41. Katsouras CS, Leontaridou C, Achenbach K, et al. Echocardiographic evidence of posteromedial hypokinesis of the left ventricle in relation to mitral regurgitation in cardiac sarcoidosis. Heart Vessels 2006; 21:382-384.
42. Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989; 63:478-482. (Pubitemid 19065326)
43. Uemura A, Morimoto S, Kato Y, et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:63-65. (Pubitemid 40444736)
44. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med 1994; 19:522-526. (Pubitemid 24180757)
45. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2- deoxy-D-glucose positron emission tomography. Clin Chest Med 1997; 18:799-811. (Pubitemid 27525442)
46. Le GD, Menad F, Faraggi M, et al. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994; 106:1675-1682. (Pubitemid 24375125)
47. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107:330-334.
48. Pellegrino D, Bonab AA, Dragotakes SC, et al. Inflammation and infection: Imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med 2005; 46:1522-1530. (Pubitemid 46177970)
49. Tahara N, Tahara A, Nitta Y, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010; 3:1219-1228.
50. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005; 26:1538-1543. (Pubitemid 41373496)
51. Youseff G, Leung E, Mylonas I, et al. The use of 18F-FDG PET imaging indiagnosis of cardiac sarcoid: A systematic review including the Ontario experience. J Nucl Med (in press).
52. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003; 44:1030-1036. (Pubitemid 39663376)
53. Cummings KW, Bhalla S, Javidan-Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 2009; 29:89-103.
54. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005; 184:249-254. (Pubitemid 40040938)
55. Ichinose A, Otani H, Oikawa M, et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol 2008; 191:862-869.
56. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45:1683-1690. (Pubitemid 40704507)
57. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18F-fluoro-2- deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008; 35:933-941.
58. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008; 133:1426-1435. (Pubitemid 351893001)
59. Matoh F, Satoh H, Shiraki K, et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 2008; 51:179-188. (Pubitemid 351718494)
60. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A cientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007; 50:1914-1931.
61. Mehta D, Mori N, Goldbarg SH, et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2011; 4:43-48.
62. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 82:537-540. (Pubitemid 28389961)
63. Ardehali H, Howard DL, Hariri A, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 150:459-463. (Pubitemid 41317613)
64. Ayyala US, Nair AP, Padilla ML. Cardiac sarcoidosis. Clin Chest Med 2008; 29:493-508; ix. (Pubitemid 351778211)
65. Stees CS, Khoo MS, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2010; 22:210-213.
66. Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicenter registry. Heart Rhythm 2009; 6:189-195.
67. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95:143-146. (Pubitemid 40051133)
68. Kato Y, Morimoto S, Uemura A, et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:133-137. (Pubitemid 36841694)
69. Takeda N, Yokoyama I, Hiroi Y, et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 2002; 105:1144-1145. (Pubitemid 34212627)
70. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011; 16:140-147.
71. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 2008; 5:934-955.
72. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: Control with augmented corticosteroids. J Heart Lung Transplant 1992; 11:367-369.
73. Judson MA. Cardiac sarcoidosis: There is no instant replay. Chest 2005; 128:3-6. (Pubitemid 40994442)
74. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010; 52:336-346.
75. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006; 28:627-636. (Pubitemid 44794680)
76. Hamzeh NY, Wamboldt FS, Weinberger HD. Management of cardiac sarcoidosis in the United States: A Delphi study. Chest 2011. [Epub ahead of print]